Radiation Oncology Journal

High-risk prostate cancer treated with a stereotactic body radiation therapy boost following pelvic nodal irradiation

Jonathan W. Lischalk, Meredith Akerman, Michael C. Repka, Astrid Sanchez, Christopher Mendez, Vianca F. Santos, Todd Carpenter, David Wise, Anthony Corcoran, Herbert Lepor, Aaron Katz, Jonathan A. Haas

Frontiers in Oncology.2024;[Epub] CrossRef

Retrospective study on the toxicity induced by stereotactic body radiotherapy: overview of the reunion experience on prostate cancer in elderly patients

Youssef Slama, Gilles Baumont, Angelique Arcambal, Mickael Begue, Olivier Maillot, Rima Sayah, Romain Castanet, Raoul Caboche, Pedro Liberati, Hakim Slaoui, Medi Bouaziz, Olivier Borson, Nam P. Nguyen, Fabien Dutheil

Frontiers in Oncology.2024;[Epub] CrossRef

Stereotactic Body Radiation Therapy in Prostate Cancer: Where Do We Stand?

Kaustav Talapatra, Kiron G, Amrutha Mohan, Nikhil Bardeskar, Hemant Tongaonkar

Journal of Current Oncology.2023; 6(1): 22. CrossRef

Bowel and Bladder Reproducibility in Image Guided Radiation Therapy for Prostate Cancer: Results of a Patterns of Practice Survey

Lindsay S. Rowe, Jeremy J. Mandia, Kilian E. Salerno, Uma T. Shankavaram, Shaoli Das, Freddy E. Escorcia, Holly Ning, Deborah E. Citrin

Advances in Radiation Oncology.2022; 7(5): 100902. CrossRef

Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer

Mark N. Alshak, Andrew Eidelberg, Susana Martinez Diaz, Michelina D. Stoddard, Silvia Formenti, Himanshu Nagar, Josephine Kang, Bilal Chughtai

World Journal of Urology.2022; 40(5): 1143. CrossRef

Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer

Emile Gogineni, Zaker Rana, Danielle Soberman, Baho Sidiqi, Vincent D'Andrea, Lucille Lee, Louis Potters, Bhupesh Parashar

International Journal of Radiation Oncology*Biology*Physics.2021; 109(5): 1232. CrossRef

Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response

Kyle Wang, Panayiotis Mavroidis, Trevor J. Royce, Aaron D. Falchook, Sean P. Collins, Stephen Sapareto, Nathan C. Sheets, Donald B. Fuller, Issam El Naqa, Ellen Yorke, Jimm Grimm, Andrew Jackson, Ronald C. Chen

International Journal of Radiation Oncology*Biology*Physics.2021; 110(1): 237. CrossRef

Resident experience in brachytherapy: An analysis of Accreditation Council for Graduate Medical Education case logs for intracavitary and interstitial brachytherapy from 2007 to 2018

Ashwin Shinde, Richard Li, Arya Amini, Neha Vapiwala, Peter Orio, John A. Vargo, Catheryn Yashar, Yi-Jen Chen, Sushil Beriwal, Scott Glaser

Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States

Sean S. Mahase, Debra D’Angelo, Josephine Kang, Jim C. Hu, Christopher E. Barbieri, Himanshu Nagar

JAMA Network Open.2020; 3(2): e1920471. CrossRef

A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer

Mark A. Ritter, Patrick A. Kupelian, Daniel G. Petereit, Colleen A. Lawton, Nick Anger, Heather Geye, Richard J. Chappell, Jeffrey D. Forman

Practical Radiation Oncology.2020; 10(5): 345. CrossRef

SBRT for Localized Prostate Cancer: Is it Ready for Take-Off?

Timur Mitin, Ann Henry, Ananya Choudhury, Ronald C. Chen, Michael Pinkawa, Daniel E. Spratt

International Journal of Radiation Oncology*Biology*Physics.2019; 105(3): 618. CrossRef

Stereotactic body radiation therapy (SBRT) for high-risk prostate cancer: Where are we now?

Practical Radiation Oncology.2018; 8(3): 185. CrossRef

Utilization of Stereotactic Radiosurgery for Renal Cell Carcinoma Brain Metastases

Waqar Haque, Vivek Verma, E.Brian Butler, Bin S. Teh

Clinical Genitourinary Cancer.2018; 16(4): e935. CrossRef

Optimal collimator rotation based on the outline of multiple brain targets in VMAT

Jung-in Kim, Beom Seok Ahn, Chang Heon Choi, Jong Min Park, So-Yeon Park

Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes

Donald B. Fuller, Aaron D. Falchook, Tami Crabtree, Brent L. Kane, Clinton A. Medbery, Kelly Underhill, James R. Gray, Anuj Peddada, Ronald C. Chen

European Urology Oncology.2018; 1(6): 540. CrossRef